استمتع بـUnlimited مع Magzter GOLD

استمتع بـUnlimited مع Magzter GOLD

احصل على وصول غير محدود إلى أكثر من 9000 مجلة وصحيفة وقصة مميزة مقابل

$149.99
 
$74.99/سنة

يحاول ذهب - حر

Copy editors, Oxford commas and other pestilences

July 21, 2024

|

THE WEEK India

SOMEONE TOLD ME years ago that J.K. Rowling, author of all that Harry Potter nonsense, had her first manuscript rejected eleventy-six times before becoming a sensational bestseller.

- K.C. VERMA

Copy editors, Oxford commas and other pestilences

Well, dear Joanne certainly had far greater stamina, tenacity and perseverance than I do. My patience and optimism ran out after my magnum opus was rejected by three publishers. But, before throwing in the towel (and my typewriter after it), I thought I would make one last attempt. And voila! The fourth publisher accepted the manuscript and made me sign a contract undertaking to publish my masterpiece in a matter of a few months. Then I heard nothing for more than three years.

Suddenly, last month, the editorial team of the publishing house wrote to me to get my manuscript ready for publication. "But wait!" I wrote back. "What do you mean ready for publication? Haven't I already given it to you? So, publish the damn thing!"

But no, that was not to be. I was then educated by some underling with an unimpressive designation about the procedure that would be adopted to actually publish my bestseller. I had expected someone with a grand-sounding title-like the Supreme Principal Editor in Chief-to call me up and beg me to come to their office to collect humongous royalties. Instead, I had got an email from a lowly assistant co-editor named Hrisha who claimed that she would find mistakes (not errors) in my masterpiece. I was offended! By Jove, was I offended!

المزيد من القصص من THE WEEK India

THE WEEK India

THE WEEK India

Fire, smoke and soaring worries

The PSLV C-62 fiasco is a stress test of ISRO's technical systems, organisational processes and market credibility

time to read

7 mins

January 25, 2026

THE WEEK India

THE WEEK India

The dinosaur and the dictator

Dictators have a few things in common with T. rex, the king of dinosaurs. Both dominate their sphere of influence through brute force.

time to read

2 mins

January 25, 2026

THE WEEK India

We are developing master plans for tourism destinations

Across the world, the tourism development is more about providing seamless connection and basic infra like transportation, lodging and boarding.

time to read

2 mins

January 25, 2026

THE WEEK India

THE WEEK India

A TIGHTROPE WALK

As small-caps are yet to find valuation comfort, 2026 would be a challenging year for them

time to read

4 mins

January 25, 2026

THE WEEK India

THE WEEK India

ON THIN ICE

With the intensification of great-power rivalries in the region, Greenland's strategic and resource potential has become salient

time to read

5 mins

January 25, 2026

THE WEEK India

THE WEEK India

Elgin, Ephesus and Erdogan

Lord Elgin was wrong. Not the eighth earl whom we know as a viceroy of India, but his more famous father, the seventh who had carted away the Parthenon Marbles from Athens during 1802-1812. Elgin feared the Ottoman Turks, who had occupied Greece, might vandalise them.

time to read

2 mins

January 25, 2026

THE WEEK India

THE WEEK India

Art at the heart

The sixth edition of the Kochi-Muziris Biennale reclaims its legacy

time to read

6 mins

January 25, 2026

THE WEEK India

THE WEEK India

BENIGN PROSTATIC HYPERPLASIA (BPH): Understanding Symptoms, Diagnosis & Modern Treatment Options

Benign Prostatic Hyperplasia (BPH) is a very common medical condition affecting aging men, particularly those above 50 years.

time to read

2 mins

January 25, 2026

THE WEEK India

THE WEEK India

ERA OF THE NEW NORMAL

The confrontations with China and Pakistan have added another dimension to the ever-evolving nature of the Indian military

time to read

5 mins

January 25, 2026

THE WEEK India

THE WEEK India

Affordable CAR-T Therapy Brings New Hope for Blood Cancer Patients in India

For thousands of Indians battling blood cancers, a once-unimaginable dream is fast becoming reality. Cutting-edge CART cell therapy a breakthrough treatment that uses a patient's own immune system to fight cancer is now available in India at a fraction of global costs, offering renewed hope to patients with advanced disease.

time to read

1 mins

January 25, 2026

Listen

Translate

Share

-
+

Change font size